Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Baptist Health Herbert Wertheim Cancer Institute Treats Its 100th CAR T-Cell Therapy Patient
Baptist Health Herbert Wertheim Cancer Institute has reached a significant milestone in cancer care: the treatment of its 100th patient with CAR T-cell therapy.
Report the Institute’s milestone of treating its 100th patient with CAR T-cell therapy and describe its program and care team.
Approach:
Treatment process: A patient’s T cells are collected, genetically modified to recognize cancer, expanded in a laboratory, and infused after preparatory chemotherapy.
Program structure: The article describes onsite cell processing in a certified GMP laboratory, FACT accreditation for the Blood and Marrow Stem Cell Transplant Program, Memorial Sloan Kettering Cancer Alliance membership, and dedicated inpatient care at Hope Tower.
Team: The program is led by Guenther Koehne, M.D., Ph.D., and involves physicians, advanced practice providers, nurses, coordinators, cellular therapy specialists, pharmacists, and support staff.
Key Findings:
The Institute reports treating its 100th patient with CAR T-cell therapy.
The article describes CAR T-cell therapy as a treatment using a patient’s modified T cells to detect and eliminate cancer cells.
The Institute credits multidisciplinary collaboration and specialized facilities with supporting the treatment program.
Interpretation:
The article presents the 100-patient milestone as recognition of the Institute’s CAR T-cell therapy and Blood and Marrow Transplantation teams.
Limitations:
The article does not provide patient outcomes, treatment indications, adverse-event data, or comparative results.
The article does not specify the time period over which the 100 patients were treated.